{"nct_id":"NCT05384587","title":"Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-11-11","start_date_type":"ACTUAL","primary_completion_date":"2025-08-13","primary_completion_date_type":"ACTUAL","completion_date":"2027-10-17","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NVS"]}